Skip to main content

MONTELUKAST SODIUM

NDC 62135-781 · Chartwell RX, LLC

Generic nameMONTELUKAST SODIUM
Dosage formTABLET, CHEWABLE
RouteORAL
Active ingredient(s)MONTELUKAST SODIUM
Strength4 mg/1
Pharmacologic classLeukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]
Marketing categoryANDA

Packages

62135-781-30 — 30 TABLET, CHEWABLE in 1 BOTTLE (62135-781-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50268-573 — Montelukast Sodium, 50268-574 — Montelukast Sodium, 55111-593 — Montelukast Sodium, 55111-594 — Montelukast Sodium, 55111-725 — Montelukast Sodium, 55154-8075 — Montelukast Sodium, 57237-212 — Montelukast Sodium, 57237-213 — Montelukast Sodium, 57237-255 — Montelukast Sodium, 59651-329 — Montelukast Sodium, 62135-782 — MONTELUKAST SODIUM, 62175-204 — Montelukast Sodium, 62175-205 — Montelukast Sodium, 63187-430 — Montelukast Sodium, 63187-550 — Montelukast Sodium, 63187-626 — MONTELUKAST, 63187-692 — MONTELUKAST SODIUM, 63187-751 — MONTELUKAST SODIUM, 63187-781 — Montelukast Sodium, 63187-896 — Montelukast Sodium, +61 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels